Shelton Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
CRM
VNIM
CNB
Shelton Wealth Management's LLY Position: Q2 2026 in Review
Shelton Wealth Management increased its Eli Lilly (LLY) stake by 17% in Q2 2026, buying an estimated $202K and bringing the position to 1,361 shares worth $1.63M. The position accounts for 0.64% of the portfolio, ranked #47.
Shelton Wealth Management first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 866 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Shelton Wealth Management held 1,361 shares of Eli Lilly worth $1.63M as of Q2 2026.
- Shelton Wealth Management bought 198 Eli Lilly shares in Q2 2026, an estimated $202K.
- Eli Lilly made up 0.64% of Shelton Wealth Management's portfolio in Q2 2026, its #47 holding.
- Shelton Wealth Management first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
- 866 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Shelton Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.